{
  "id": 15631328,
  "title": "Disc’s once-spurned rare disease drug to get a second chance at approval",
  "url": "https://urgent.news/2026/10/19/discs-once-spurned-rare-disease-drug-to-get-a-second-chance-at",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-19T16:27:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/Disc-bitopertin-apollo-erythropoietic-protoporphyria-study-results/833327/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Months after the FDA rejected its treatment for a rare light-sensitivity disease, the biotech claimed success in a Phase 3 trial and now plans to re-engage regulators.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}